15.15
price up icon1.07%   0.16
after-market Dopo l'orario di chiusura: 15.11 -0.04 -0.26%
loading
Precedente Chiudi:
$14.99
Aprire:
$15.12
Volume 24 ore:
2.86M
Relative Volume:
1.11
Capitalizzazione di mercato:
$3.61B
Reddito:
$510.17M
Utile/perdita netta:
$146.93M
Rapporto P/E:
25.29
EPS:
0.599
Flusso di cassa netto:
$27.51M
1 W Prestazione:
-1.56%
1M Prestazione:
-5.84%
6M Prestazione:
-5.96%
1 anno Prestazione:
-15.41%
Intervallo 1D:
Value
$14.86
$15.22
Intervallo di 1 settimana:
Value
$14.86
$16.18
Portata 52W:
Value
$13.76
$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Name
Nome
Adma Biologics Inc
Name
Telefono
(201) 478-5552
Name
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Name
Dipendente
647
Name
Cinguettio
@AdmaBiologics
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
ADMA's Discussions on Twitter

Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ADMA
Adma Biologics Inc
15.15 3.61B 510.17M 146.93M 27.51M 0.599
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.34 119.23B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
745.77 78.84B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
700.45 43.35B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
313.41 41.57B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
284.05 31.51B 5.36B 287.73M 924.18M 2.5229

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-07-19 Ripresa Raymond James Strong Buy
2022-10-13 Iniziato Mizuho Buy
2021-11-11 Aggiornamento Raymond James Outperform → Strong Buy
2021-11-09 Iniziato Cantor Fitzgerald Overweight
2019-06-04 Iniziato Jefferies Buy
2019-04-15 Reiterato H.C. Wainwright Buy
2019-02-07 Ripresa H.C. Wainwright Buy
2017-12-11 Reiterato Maxim Group Buy
2017-11-14 Aggiornamento Raymond James Mkt Perform → Outperform
2017-01-23 Aggiornamento Maxim Group Hold → Buy
2016-08-01 Downgrade Maxim Group Buy → Hold
2016-07-25 Reiterato Maxim Group Buy
2015-05-13 Reiterato Maxim Group Buy
2014-12-08 Iniziato Oppenheimer Outperform
2014-12-01 Reiterato Maxim Group Buy
Mostra tutto

Adma Biologics Inc Borsa (ADMA) Ultime notizie

pulisher
01:21 AM

Reassessing ADMA Biologics (ADMA) After Multi Year Surge And Recent Share Price Pullback - simplywall.st

01:21 AM
pulisher
Mar 13, 2026

Why the Market Dipped But Adma Biologics (ADMA) Gained Today - Yahoo Finance

Mar 13, 2026
pulisher
Mar 12, 2026

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Mar 12, 2026
pulisher
Mar 12, 2026

Best Momentum Stocks to Buy for March 12th - Yahoo Finance Singapore

Mar 12, 2026
pulisher
Mar 12, 2026

New Strong Buy Stocks for March 12th - Yahoo Finance Singapore

Mar 12, 2026
pulisher
Mar 12, 2026

Price-Driven Insight from (ADMA) for Rule-Based Strategy - Stock Traders Daily

Mar 12, 2026
pulisher
Mar 10, 2026

Insider Selling: ADMA Biologics (NASDAQ:ADMA) COO Sells $157,800.48 in Stock - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

ADMA (NASDAQ: ADMA) files Form 144 showing RSU vesting and proposed sales - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

ADMA (ADMA) CEO uses 85,951 shares to cover RSU tax obligations - Stock Titan

Mar 10, 2026
pulisher
Mar 09, 2026

ADMA Biologics (NASDAQ: ADMA) proposes sale of option-exercise shares on 03/09/2026 - Stock Titan

Mar 09, 2026
pulisher
Mar 09, 2026

ADMA Biologics (NASDAQ:ADMA) Director Buys $109,690.00 in Stock - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

New ADMA Biologics CFO Puts Focus On Margins And Capital Allocation - Yahoo Finance

Mar 08, 2026
pulisher
Mar 06, 2026

Returns Recap: Is ADMA Biologics Inc subject to activist investor interestTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Segall Bryant & Hamill LLC Reduces Stock Position in ADMA Biologics Inc $ADMA - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

ADMA Biologics Buyback Plan Tests Earnings Story And Valuation Gap - simplywall.st

Mar 05, 2026
pulisher
Mar 05, 2026

Legato Capital Management LLC Has $433,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

American Century Companies Inc. Purchases 84,934 Shares of ADMA Biologics Inc $ADMA - MarketBeat

Mar 05, 2026
pulisher
Mar 04, 2026

Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside? - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Research - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

ADMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

ADMA Biologics (ADMA) Q4 2025 Earnings Transcript - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Finviz

Mar 03, 2026
pulisher
Mar 03, 2026

Royce & Associates LP Acquires 292,819 Shares of ADMA Biologics Inc $ADMA - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

ADMA Biologics Inc $ADMA Shares Bought by Rafferty Asset Management LLC - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

ADMA Biologics (ADMA) CEO withholds 54,858 shares to cover RSU tax obligations - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics (ADMA) Announces $200M Capital Return Plan for 20 - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics Announces $200 Mln Capital Return Plan - Nasdaq

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics Launches Major 2026 Capital Return Plan - TipRanks

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan. - Bitget

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics launches $125M accelerated share repurchase as part of ~$200M 2026 buyback plan - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics (ADMA) launches $125M accelerated buyback in $200M 2026 plan - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ADMA Biologics commits $125M into rapid buyback, targets $200M in 2026 - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Feb 28, 2026
pulisher
Feb 28, 2026

ADMA Biologics (ADMA) Valuation After Revenue Growth Guidance Reaffirmation And CFO Transition - simplywall.st

Feb 28, 2026
pulisher
Feb 28, 2026

ADMA Biologics (ADMA) Margin Compression Challenges Bullish Growth Narratives Heading Into Earnings - Sahm

Feb 28, 2026
pulisher
Feb 28, 2026

Vanguard Group Inc. Sells 388,719 Shares of ADMA Biologics Inc $ADMA - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

ADMA Biologics (NASDAQ:ADMA) Upgraded at Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

ADMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 27, 2026
pulisher
Feb 26, 2026

ADMA Biologics (NASDAQ: ADMA) CFO details stock and option holdings - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

A Look At ADMA Biologics (ADMA) Valuation After Record Results Guidance And CFO Appointment - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance - Finviz

Feb 26, 2026
pulisher
Feb 26, 2026

ADMA Biologics Inc earnings beat by $0.01, revenue fell short of estimates - Investing.com Nigeria

Feb 26, 2026
pulisher
Feb 26, 2026

Westfield Capital Management Co. LP Takes $74.87 Million Position in ADMA Biologics Inc $ADMA - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

ADMA Biologics CFO Shift Puts Spotlight On Margins And Valuation - simplywall.st

Feb 26, 2026
pulisher
Feb 26, 2026

New ADMA Biologics CFO Takes Helm As Valuation Gap Draws Focus - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

ADMA Biologics Inc (ADMA) Q4 2025 Earnings Call Highlights: Stro - GuruFocus

Feb 26, 2026
pulisher
Feb 25, 2026

ADMA Biologics (ADMA) Reports Strong 2025 Results and Positive O - GuruFocus

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI

Feb 25, 2026
pulisher
Feb 25, 2026

ADMA Biologics Q4 2025 Earnings Call Transcript - MarketBeat

Feb 25, 2026

Adma Biologics Inc Azioni (ADMA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):